Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer

Clinical Breast Cancer

Volumn 8, Issue 1, 2008, Pages 80-87

  Kreukels, Baudewijntje P C ^a,b   Van Dam, Frits S A M ^a,c   Ridderinkhof, K Richard ^c,d   Boogerd, Willem ^a,e   Schagen, Sanne B ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

^e SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Blood brain barrier; Cognitive dysfunction; Electrophysiology; P3 Latency

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; ARTICLE; BEHAVIOR; BRAIN FUNCTION; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NEUROPSYCHOLOGICAL TEST; TASK PERFORMANCE;

EID: 40449110999     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2008.n.006     Document Type: Article

References (46)

1. TA Ahles AJ Saykin CT Furstenberg Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma J Clin Oncol 20 2002 485 493
2. CB Brezden KA Phillips M Abdolell Cognitive function in breast cancer patients receiving adjuvant chemotherapy J Clin Oncol 18 2000 2695 2701
3. SA Castellon PA Ganz JE Bower Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen J Clin Exp Neuropsychol 26 2004 955 969
4. SB Schagen MJ Muller W Boogerd Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients J Natl Cancer Inst 98 2006 1742 1745
5. V Shilling V Jenkins R Morris The effects of adjuvant chemotherapy on cognition in women with breast cancer: preliminary results of an observational longitudinal study Breast 14 2005 142 150
6. FS van Dam SB Schagen MJ Muller Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy J Natl Cancer Inst 90 1998 210 218
7. JS Wefel R Lenzi RL Theriault The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial Cancer 100 2004 2292 2299
8. SB Schagen FS van Dam MJ Muller Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma Cancer 85 1999 640 650
9. BP Kreukels SB Schagen KR Ridderinkhof Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy Breast Cancer Res Treat 94 2005 53 61
10. SA Castellon DH Silverman PA Ganz Breast cancer treatment and cognitive functioning: current status and future challenges in assessment Breast Cancer Res Treat 2 2005 199 206
11. MW van der Molen TR Bashore R Halliday Chronopsychophysiology: mental chronometry augmented by psychophysiological time markers JR Jennings MGH Coles Handbook of Cognitive Psychophysiology: Central and Autonomic Nervous System Approaches 1991 John Wiley & Sons Chichester 9 178
12. R Reitan Validity of the Trail Making Test as an indicator of organic brain damage Percept Mot Skills 8 1958 271 276
13. D Wechsler Wechsler Adult Intelligence Scale 1955 Psychological Corp New York
14. J Hammes De Stroop Kleur-Woord Test. Handleiding 2nd ed. 1978 Swets & Zeitlinger Lisse
15. EJ Zeef A Kok Age-related differences in the timing of stimulus and response processes during visual selective attention: performance and psychophysiological analyses Psychophysiology 30 1993 138 151
16. M van der Linden S Bredart A Beerten Age-related differences in updating working memory Br J Psychol 85 pt 1 1994 145 152
17. JL Mulder R Dekker PH Dekker Verbale Leer & Geheugen Test 1996 Swets & Zeitlinger Lisse
18. D Wechsler Wechsler Memory Scale: Revised 1987 Psychological Corp New York
19. AF Sanders Towards a model of stress and human performance Acta Psychol (Amst) 53 1983 61 97
20. AF Sanders Issues and trends in the debate on discrete vs. continuous processing of information Acta Psychol 74 1990 123 167
21. F Luteijn FAE van der Ploeg GIT Groninger Intelligentie Test 1973 Swets & Zeitlinger Lisse
22. W Alpherts AP Aldenkamp FePsy: The Iron Psyche 1994 Instituut voor Epilepsiebestrijding Heemstede
23. B Schmand J Lindeboom F van Harskamp De Nederlandse Leestest voor Volwassenen 1992 Swets & Zeitlinger Lisse
24. DS Goodin Clinical utility of long latency ‘cognitive’ event-related potentials (P3): the pros Electroencephalogr Clin Neurophysiol 76 1990 2 5
25. H Saito H Yamazaki H Matsuoka Visual event-related potential in mild dementia of the Alzheimer's type Psychiatry Clin Neurosci 55 2001 365 371
26. SB Schagen HL Hamburger MJ Muller Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function J Neurooncol 51 2001 159 165
27. BP Kreukels SB Schagen KR Ridderinkhof Effects of highdose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study Clin Breast Cancer 7 2006 67 78
28. LR Derogatis RS Lipman K Rickels The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions Mod Probl Pharmacopsychiatry 7 1974 79 110
29. PT Hesbacher K Rickels RJ Morris Psychiatric illness in family practice J Clin Psychiatry 41 1980 6 10
30. N de Jong MJ Candel HC Schouten Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy Ann Oncol 15 2004 896 905
31. EM Smets B Garssen B Bonke Het Meten van Vermoeidheid met de Multidimensionele Vermoeidheids Index (MVI-20): Een Handleiding 1995 Medische Psychologie, Academisch Medisch Centrum Amsterdam, The Netherlands
32. DG Altman Practical Statistics for Medical Research 1991 Chapman & Hall London 74 103
33. A Field Discovering Statistics using SPSS for Windows 2000 SAGE Publications London
34. J Cohen Statistical Power Analysis for the Behavioral Sciences 2nd ed. 1988 Lawrence Erlbaum, Hillsdale, NJ
35. IF Tannock TA Ahles PA Ganz Cognitive impairment associated with chemotherapy for cancer: report of a workshop J Clin Oncol 22 2004 2233 2239
36. R Kail TA Salthouse Processing speed as a mental capacity Acta Psychol (Amst) 86 1994 199 225
37. TA Salthouse The processing-speed theory of adult age differences in cognition Psychol Rev 103 1996 403 428
38. C Anderson-Hanley ML Sherman R Riggs Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature J Int Neuropsychol Soc 9 2003 967 982
39. A Pfefferbaum WT Roth JM Ford Event-related potentials in the study of psychiatric disorders Arch Gen Psychiatry 52 1995 559 563
40. EM Kemper W Boogerd I Thuis Modulation of the bloodbrain barrier in oncology: therapeutic opportunities for the treatment of brain tumours? Cancer Treat Rev 30 2004 415 423
41. JS Wefel AE Kayl CA Meyers Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target Br J Cancer 90 2004 1691 1696
42. W Boogerd Neurological complications of chemotherapy Vinken Bruyn Handbook of Clinical Neurology: Intoxications of the Nervous System Part II 1995 Elsevier Science Amsterdam, The Netherlands 527 546
43. G Winocur J Vardy MA Binns The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice Pharmacol Biochem Behav 85 2006 66 75
44. R Seigers SB Schagen W Beerling Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat Behav Brain Res 186 2008 168 175
45. DH Silverman CJ Dy SA Castellon Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy Breast Cancer Res Treat 103 2006 303 311
46. M Inagaki E Yoshikawa Y Matsuoka Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy Cancer 109 2007 146 156